Autobahn Labs
Mark Slack, VP Academic Partnerships, is responsible at Evotec for the establishment and execution of Evotec´s Academic BRIDGE activities. Through his EIR role Mark works closely with TTOs, leading academics and investors to identify and develop novel drug discovery opportunities, to develop these through the preclinical drug discovery cascade, through to spinout. Through his 20 years of drug discovery accrued within Evotec and Pharma, Mark provides operational guidance to help develop projects, to maximize their potential and build a sustainable investment portfolio.
This person is not in the org chart
This person is not in any offices
Autobahn Labs
Autobahn Labs is collaboration between a Samsara BioCapital-led investor syndicate and Evotec.